Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from subjects with Type II diabetes mellitus

被引:61
作者
Rondinone, CM [1 ]
Carvalho, E [1 ]
Wesslau, C [1 ]
Smith, UP [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Internal Med, Lundberg Lab Diabet Res, S-41345 Gothenburg, Sweden
关键词
PKB; insulin; okadaic acid; Type II diabetes; glucose transport;
D O I
10.1007/s001250051232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. To study the effects of insulin and okadaic acid, a serine/threonine phosphatase inhibitor which does not increase PI3-kinase activity, on the rare of glucose transport and protein kinase B activation in adipocytes from healthy subjects and subjects with Type II (non-insulin-dependent) diabetes mellitus. Methods. Adipocytes were incubated with or without insulin or okadaic acid or both and glucose transport, protein kinase B activity, phosphorylation and protein expression measured. Results. Insulin and okadaic acid alone increased glucose uptake to a similar degree in adipocytes from healthy subjects and, when combined, exerted a partial additive effect. The effect of insulin was reduced by about 60 % in adipocytes from Type II diabetic patients, whereas the effect of okadaic acid was essentially unchanged and no further increase was seen when okadaic acid and insulin were combined. Okadaic acid increased protein kinase B activity to a greater extent (two to threefold) than insulin but only slightly increased the serine phosphorylation of protein kinase B. Adipocytes from Type II diabetic subjects exhibited both an impaired sensitivity as well as a reduced total serine phosphorylation and activation of protein kinase B in response to insulin but protein kinase B activity in response to okadaic acid was intact. Conclusion/interpretation. These results show that the ability of insulin to increase glucose transport and activate protein kinase B is reduced in fat cells from Type II diabetic subjects. Protein kinase B can, however, be activated by agents like okadaic acid which bypass the upstream defects in the insulin signalling pathway in Type II diabetic cells and, thus, increase glucose uptake.
引用
收藏
页码:819 / 825
页数:7
相关论文
共 36 条
  • [11] Mechanisms and consequences of activation of protein kinase B/Akt
    Downward, J
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) : 262 - 267
  • [12] Regulation of neuronal survival by the serine-threonine protein kinase Akt
    Dudek, H
    Datta, SR
    Franke, TF
    Birnbaum, MJ
    Yao, RJ
    Cooper, GM
    Segal, RA
    Kaplan, DR
    Greenberg, ME
    [J]. SCIENCE, 1997, 275 (5300) : 661 - 665
  • [13] REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY IN LIVER AND MUSCLE OF ANIMAL-MODELS OF INSULIN-RESISTANT AND INSULIN-DEFICIENT DIABETES-MELLITUS
    FOLLI, F
    SAAD, MJA
    BACKER, JM
    KAHN, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1787 - 1794
  • [14] THE PROTEIN-KINASE ENCODED BY THE AKT PROTOONCOGENE IS A TARGET OF THE PDGF-ACTIVATED PHOSPHATIDYLINOSITOL 3-KINASE
    FRANKE, TF
    YANG, SI
    CHAN, TO
    DATTA, K
    KAZLAUSKAS, A
    MORRISON, DK
    KAPLAN, DR
    TSICHLIS, PN
    [J]. CELL, 1995, 81 (05) : 727 - 736
  • [15] Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
    Franke, TF
    Kaplan, DR
    Cantley, LC
    Toker, A
    [J]. SCIENCE, 1997, 275 (5300) : 665 - 668
  • [16] PRETRANSLATIONAL SUPPRESSION OF A GLUCOSE TRANSPORTER PROTEIN CAUSES INSULIN RESISTANCE IN ADIPOCYTES FROM PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND OBESITY
    GARVEY, WT
    MAIANU, L
    HUECKSTEADT, TP
    BIRNBAUM, MJ
    MOLINA, JM
    CIARALDI, TP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) : 1072 - 1081
  • [17] Signal transduction - Akt signaling: Linking membrane events to life and death decisions
    Hemmings, BA
    [J]. SCIENCE, 1997, 275 (5300) : 628 - 630
  • [18] DEFECT IN SKELETAL-MUSCLE PHOSPHATIDYLINOSITOL-3-KINASE IN OBESE INSULIN-RESISTANT MICE
    HEYDRICK, SJ
    JULIEN, D
    GAUTIER, N
    TANTI, JF
    GIORGETTI, S
    VAN OBBERGHEN, E
    LE MARCHAND-BRUSTEL, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1358 - 1366
  • [19] Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
    Kerouz, NJ
    Hörsch, D
    Pons, S
    Kahn, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 3164 - 3172
  • [20] Kim YB, 1998, DIABETES, V47, pA7